PATENT CLAIM ANALYSIS

Application Number: 15866303
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "561000"]

Abstract:
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, suicidal ideation and/or behavior, obsessive compulsive disorder or Alzheimer's disease). Also provided herein are methods for preparing the co-crystals.

Claim (Index 17):
The co-crystal of  claim 14 , wherein the molecular ratio between the N-methylglycine and fumaric acid in the co-crystal is 6:1, and wherein the co-crystal has a powder X-ray diffraction pattern at a 2\u03b8 angle with peaks (\u00b0) of: 9.66, 12.30, 15.00, 16.55, 17.07, 18.51, 19.98, 20.39, 22.43, 22.79, 23.43, 24.63, 24.99, 25.84, 26.06, 26.92, 27.11, 27.90, 28.17, 29.05, 29.40, 30.19, 30.49, 32.81, 33.29, 33.34, 34.52, 34.76, 34.97, 35.20, 35.57, 35.99, 37.75, and 38.36.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 86.0
- Lexical Diversity: 1.35849
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15430750', '15188545', '14358606', '14799281', '14777018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7809955854446217
- 35 USC 102 Novelty (BERT): 0.5645890032641478
- Combined Prediction Score: 0.7593549272265743
- Mean Citation Score: 320.9926200000001
- Max Citation Score: 471.8377
- Similarity Product: 337.8105758990645

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test